← Back to Patent Explorer
US6092528A Expired / Lapsed US ⏱️ 0.0 years remaining

Method to treat esophageal sphincters

Assignee: Venture Banking Group
•
Filing: 1998-03-06
•
Granted: 2000-07-25
•
Expires: 2018-03-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method of treating a sphincter provides a treatment apparatus that includes an expandable device coupled to an introducer distal portion and an energy delivery device. The expandable device includes a first arm and a second arm each with proximal and distal section. The expandable member has a non-deployed configuration and a deployed configuration when the first and second arm distend away from each other. The expandable device is at least partially introduced in the sphincter. At least a portion of the energy delivery device is advanced from the expandable device into an interior of the sphincter. Sufficient energy is delivered from the energy delivery device to create a desired tissue effect in the sphincter. The expandable device is then removed from the sphincter.

Inventors

  • 👤 Stuart D. Edwards

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 12:53
CPC Classifications
A; A61; A61B; A61B18/00; A61B18/04; A61B18/12; A61B18/1206; A61B18/14; A61B18/1477; A61B18/148; A61B18/1485; A61B18/1492; A61M; A61M16/00; A61M16/04; A61M16/0475; A61M16/0477; A61M16/0481; A61N; A61N1/00; A61N1/02; A61N1/04; A61N1/05; A61N1/056; A61N1/06; A61N1/40; A61B18/18; A61B18/1815; A61B17/00; A61B2017/00017; A61B2017/00022; A61B2017/00084; A61B2017/00106; A61B17/00234; A61B2017/00292; A61B2017/003; A61B2017/00831; A61B2017/00867; A61B17/22; A61B2017/22051; A61B2017/22062; A61B2017/22072; A61B17/42; A61B2017/4216; A61B2018/00005; A61B2018/00011; A61B2018/00023; A61B2018/00029; A61B2018/00053; A61B2018/00059; A61B2018/00065; A61B2018/00071; A61B2018/00077; A61B2018/00083; A61B2018/00107; A61B2018/00113; A61B2018/00148; A61B2018/0016; A61B2018/00214; A61B2018/0022; A61B2018/00267; A61B2018/00315; A61B2018/00482; A61B2018/00494; A61B2018/00553; A61B2018/00559; A61B2018/00571; A61B2018/00577; A61B2018/00636; A61B2018/00642; A61B2018/00654; A61B2018/00666; A61B2018/00678; A61B2018/00696; A61B2018/00702; A61B2018/00708; A61B2018/00726; A61B2018/00738; A61B2018/00744; A61B2018/00755; A61B2018/00761; A61B2018/00773; A61B2018/00791; A61B2018/00797; A61B2018/00815; A61B2018/00821; A61B2018/00827; A61B2018/00839; A61B2018/00869; A61B2018/00875; A61B2018/00886; A61B2018/00892; A61B2018/00898; A61B2018/0091; A61B2018/00916; A61B2018/00982; A61B18/02; A61B2018/0231; A61B2018/0262; A61B2018/044; A61B2018/046; A61B2018/124; A61B2018/1246; A61B2018/1253; A61B2018/126; A61B2018/1273; A61B2018/1467; A61B2018/1472; A61B90/00; A61B90/36; A61B90/361; A61B2090/3614; A61B90/37; A61B2090/378; A61B2090/3782; A61B2218/00; A61B2218/001; A61B2218/002; A61F; A61F7/00; A61F7/12; A61M25/00; A61M25/10; A61M2025/1043; A61M2025/1052; A61M2025/1086; A61M25/1002; C; C08; C08L; C08L2201/00; C08L2201/12

Claims Analysis

Total Claims: 52
Claim 1
Independent Claim 138 words
A method of treating a sphincter, comprising: providing treatment apparatus means including an expandable device means coupled to an introducer distal portion means and an energy delivery device means, the expandable device means including a first arm means and a second arm means each with proximal and distal section means, wherein the expandable device means has a non-deployed configuration and a deployed configuration when the first and second arm means distend away from each other; introducing at least a portion of the expandable device means in the sphincter; advancing the at least a portion of the energy delivery device means from the expandable device means into an interior of the sphincter; delivering sufficient energy from the energy delivery device means to create a desired tissue effect in the sphincter; and removing the expandable device means from the sphincter.
Claim 2
Independent Claim 138 words
A method of treating a sphincter, comprising: providing treatment apparatus means including an expandable device means coupled to an introducer distal portion means and an energy delivery device means, the expandable device means including a first arm means and a second arm means each with proximal and distal section means, wherein the expandable device means has a non-deployed configuration and a deployed configuration when the first and second arm means distend away from each other; introducing at least a portion of the expandable device means in the sphincter; advancing the at least a portion of the energy delivery device means from the expandable device means into an interior of the sphincter; delivering sufficient energy from the energy delivery device means to create a desired tissue effect in the sphincter; and removing the expandable device means from the sphincter.
Claim 3
Dependent Claim 19 words
The method of claim 1, further comprising: expanding the expandable device means in the sphincter to the deployed configured.
Claim 4
Dependent Claim 18 words
The method of claim 1, further comprising: detecting a temperature of the sphincter at a selected treatment site.
Claim 5
Dependent Claim 19 words
The method of claim 1, further comprising: detecting a temperature of the sphincter at a surface of the sphincter.
Claim 6
Dependent Claim 19 words
The method of claim 1, further comprising: detecting a temperature of the sphincter in an interior of the sphincter.
Claim 7
Dependent Claim 16 words
The method of claim 1, wherein the desired tissue effect is a modification of sphincter tissue.
Claim 8
Dependent Claim 16 words
The method of claim 1, wherein the desired tissue effect is a contraction of sphincter tissue.
Claim 9
Dependent Claim 19 words
The method of claim 1, wherein the desired tissue effect is a creation of cell necrosis of sphincter tissue.
Claim 10
Dependent Claim 21 words
The method of claim 1, wherein the desired tissue effect is a creation of cell necrosis of a sub-mucosal sphincter tissue.
Claim 11
Dependent Claim 21 words
The method of claim 1, wherein the desired tissue effect is a creation of cell necrosis of a mucosal sphincter tissue.
Claim 12
Dependent Claim 13 words
The method of claim 1, wherein the sphincter is a lower esophageal sphincter.
Claim 13
Dependent Claim 24 words
The method of claim 11, wherein sufficient energy is applied to the lower esophageal sphincter to reduce a duration of lower esophageal sphincter relaxation.
Claim 14
Dependent Claim 27 words
The method of claim 11, wherein sufficient energy is applied to the lower esophageal sphincter to reduce a frequency of reflux of stomach contents into an esophagus.
Claim 15
Dependent Claim 30 words
The method of claim 11, wherein sufficient energy is applied to the lower esophageal sphincter to reduce a frequency of a symptom of reflux of stomach contents into an esophagus.
Claim 16
Dependent Claim 30 words
The method of claim 11, wherein sufficient energy is applied to the lower esophageal sphincter to reduce an incidence of a sequela of reflux of stomach contents into an esophagus.
Claim 17
Dependent Claim 29 words
The method of claim 11, wherein sufficient energy is delivered to create the desired tissue effect in the lower esophageal sphincter without permanently damaging anatomical structures near the sphincter.
Claim 18
Dependent Claim 32 words
The method of claim 11, wherein sufficient energy is delivered to create the desired tissue effect in the lower esophageal sphincter without permanently disrupting an aorta positioned near the lower esophageal sphincter.
Claim 19
Dependent Claim 33 words
The method of claim 11, wherein sufficient energy is delivered to create the desired tissue effect in the lower esophageal sphincter without permanently damaging a vagus nerve positioned near the lower esophageal sphincter.
Claim 20
Dependent Claim 43 words
The method of claim 11, wherein the energy delivery device delivers a sufficient amount of energy to create the desired tissue effect in the lower esophageal sphincter without permanently damaging an esophageal plexus of nerves and veins positioned near the lower esophageal sphincter.
Claim 21
Dependent Claim 37 words
The method of claim 11, wherein the energy delivery device delivers a sufficient amount of energy to create the desired tissue effect in the lower esophageal sphincter while preserving a blood supply to the lower esophageal sphincter.
Claim 22
Dependent Claim 33 words
The method of claim 1, wherein energy delivered to the sphincter produces the desired tissue effect without creating a permanent impairment of the sphincter's ability to achieve a physiologically normal state of closure.
Claim 23
Dependent Claim 20 words
The method of claim 1, wherein sufficient energy is delivered to cause a proliferation of fibroblast cells in the sphincter.
Claim 24
Dependent Claim 20 words
The method of claim 1, wherein sufficient energy is delivered to cause an infiltration of fibroblast cells in the sphincter.
Claim 25
Dependent Claim 20 words
The method of claim 1, wherein sufficient energy is delivered to cause a proliferation of myofibroblast cells in the sphincter.
Claim 26
Dependent Claim 20 words
The method of claim 1, wherein sufficient energy is delivered to cause an infiltration of myofibroblast cells in the sphincter.
Claim 27
Independent Claim 98 words
A method of treating a sphincter, comprising: providing treatment apparatus means including an expandable device means coupled to an introducer distal portion means and an energy delivery device means, the expandable device means including a first arm means and a second arm means each with proximal and distal section means, wherein the expandable member means has a non-deployed configuration and a deployed configuration; introducing the expandable device means in the sphincter; delivering sufficient energy from the energy delivery device means to create a desired tissue effect in the sphincter; and removing the expandable device means from the sphincter.
Claim 28
Independent Claim 98 words
A method of treating a sphincter, comprising: providing treatment apparatus means including an expandable device means coupled to an introducer distal portion means and an energy delivery device means, the expandable device means including a first arm means and a second arm means each with proximal and distal section means, wherein the expandable member means has a non-deployed configuration and a deployed configuration; introducing the expandable device means in the sphincter; delivering sufficient energy from the energy delivery device means to create a desired tissue effect in the sphincter; and removing the expandable device means from the sphincter.
Claim 29
Dependent Claim 19 words
The method of claim 26, further comprising: expanding the expandable device means in the sphincter to the deployed configured.
Claim 30
Dependent Claim 18 words
The method of claim 26, further comprising: detecting a temperature of the sphincter at a selected treatment site.
Claim 31
Dependent Claim 19 words
The method of claim 26, further comprising: detecting a temperature of the sphincter at a surface of the sphincter.
Claim 32
Dependent Claim 19 words
The method of claim 26, further comprising: detecting a temperature of the sphincter in an interior of the sphincter.
Claim 33
Dependent Claim 16 words
The method of claim 26, wherein the desired tissue effect is a modification of sphincter tissue.
Claim 34
Dependent Claim 16 words
The method of claim 26, wherein the desired tissue effect is a contraction of sphincter tissue.
Claim 35
Dependent Claim 19 words
The method of claim 26, wherein the desired tissue effect is a creation of cell necrosis of sphincter tissue.
Claim 36
Dependent Claim 21 words
The method of claim 26, wherein the desired tissue effect is a creation of cell necrosis of a sub-mucosal sphincter tissue.
Claim 37
Dependent Claim 21 words
The method of claim 26, wherein the desired tissue effect is a creation of cell necrosis of a mucosal sphincter tissue.
Claim 38
Dependent Claim 13 words
The method of claim 26, wherein the sphincter is a lower esophageal sphincter.
Claim 39
Dependent Claim 24 words
The method of claim 36, wherein sufficient energy is applied to the lower esophageal sphincter to reduce a duration of lower esophageal sphincter relaxation.
Claim 40
Dependent Claim 27 words
The method of claim 36, wherein sufficient energy is applied to the lower esophageal sphincter to reduce a frequency of reflux of stomach contents into an esophagus.
Claim 41
Dependent Claim 30 words
The method of claim 36, wherein sufficient energy is applied to the lower esophageal sphincter to reduce a frequency of a symptom of reflux of stomach contents into an esophagus.
Claim 42
Dependent Claim 30 words
The method of claim 36, wherein sufficient energy is applied to the lower esophageal sphincter to reduce an incidence of a sequela of reflux of stomach contents into an esophagus.
Claim 43
Dependent Claim 29 words
The method of claim 36, wherein sufficient energy is delivered to create the desired tissue effect in the lower esophageal sphincter without permanently damaging anatomical structures near the sphincter.
Claim 44
Dependent Claim 32 words
The method of claim 36, wherein sufficient energy is delivered to create the desired tissue effect in the lower esophageal sphincter without permanently disrupting an aorta positioned near the lower esophageal sphincter.
Claim 45
Dependent Claim 33 words
The method of claim 36, wherein sufficient energy is delivered to create the desired tissue effect in the lower esophageal sphincter without permanently damaging a vagus nerve positioned near the lower esophageal sphincter.
Claim 46
Dependent Claim 43 words
The method of claim 36, wherein the energy delivery device delivers a sufficient amount of energy to create the desired tissue effect in the lower esophageal sphincter without permanently damaging an esophageal plexus of nerves and veins positioned near the lower esophageal sphincter.
Claim 47
Dependent Claim 37 words
The method of claim 36, wherein the energy delivery device delivers a sufficient amount of energy to create the desired tissue effect in the lower esophageal sphincter while preserving a blood supply to the lower esophageal sphincter.
Claim 48
Dependent Claim 33 words
The method of claim 26, wherein energy delivered to the sphincter produces the desired tissue effect without creating a permanent impairment of the sphincter's ability to achieve a physiologically normal state of closure.
Claim 49
Dependent Claim 20 words
The method of claim 26, wherein sufficient energy is delivered to cause a proliferation of fibroblast cells in the sphincter.
Claim 50
Dependent Claim 20 words
The method of claim 26, wherein sufficient energy is delivered to cause an infiltration of fibroblast cells in the sphincter.
Claim 51
Dependent Claim 20 words
The method of claim 26, wherein sufficient energy is delivered to cause a proliferation of myofibroblast cells in the sphincter.
Claim 52
Dependent Claim 20 words
The method of claim 26, wherein sufficient energy is delivered to cause an infiltration of myofibroblast cells in the sphincter.

References Cited (Backward Citations)

US1798902A Cited
US3901241A Cited
US4011872A Cited
US4196724A Cited
US4532924A Cited
US4423812A Cited
US4565200A Cited
US4411266A Cited
US5397339A Cited
US5215103A Cited
US5365926A Cited
US4901737A Cited
US4943290A Cited
US4907589A Cited
US4947842A Cited
US4906203A Cited
US4966597A Cited
DE3838840C2 Cited
US5046512A Cited
US5057107A Cited
US5078717A Cited
US4976711A Cited
US5125928A Cited
US5035696A Cited
US5205287A Cited
US5122137A Cited
US5083565A Cited
US5100423A Cited
US5496271A Cited
US5316020A Cited
US5256138A Cited
US5088979A Cited
US5190541A Cited
US5368557A Cited
US5094233A Cited
US5688490A Cited
US5398683A Cited
US5383917A Cited
US5275608A Cited
US5275162A Cited
US5257451A Cited
US5328467A Cited
US5456682A Cited
US5363861A Cited
US5423808A Cited
US5197964A Cited
US5290286A Cited
US5197963A Cited
US5490984A Cited
US5281216A Cited
US5281217A Cited
US5368592A Cited
US5370678A Cited
US5314466A Cited
US5277201A Cited
US5281218A Cited
US5254126A Cited
US5370675A Cited
US5554110A Cited
US5542915A Cited
US5536240A Cited
US5366490A Cited
US5531676A Cited
US5531677A Cited
US5409453A Cited
US5421819A Cited
US5514131A Cited
US5540655A Cited
US5542916A Cited
US5385544A Cited
US5435805A Cited
US5484400A Cited
US5549644A Cited
US5470308A Cited
US5556377A Cited
US5293869A Cited
US5309910A Cited
US5401272A Cited
US5509419A Cited
US5313943A Cited
US5549108A Cited
US5471982A Cited
US5334196A Cited
US5383876A Cited
US5423811A Cited
US5545161A Cited
US5348554A Cited
US5486161A Cited
US5456662A Cited
DE4303882C2 Cited
US5403311A Cited
US5365945A Cited
US5520684A Cited
US5441499A Cited
US5545193A Cited
US5433739A Cited
US5458597A Cited
US5507743A Cited
US5599345A Cited
US5472441A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2003-07-25 2004-01-24 2004-07-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2007-07-25 2008-01-24 2008-07-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2011-07-25 2012-01-24 2012-07-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag